Details for New Drug Application (NDA): 208302
✉ Email this page to a colleague
NDA 208302 describes IMATINIB MESYLATE, which is a drug marketed by Amneal Pharms, Apotex, Breckenridge, Chartwell Rx, Dr Reddys, Eugia Pharma, Hikma, Mylan, Natco Pharma Ltd, Qilu Pharm Hainan, Shilpa, Sun Pharm, Teva Pharms Usa, and Zydus Pharms, and is included in fourteen NDAs. It is available from twenty-two suppliers. Additional details are available on the IMATINIB MESYLATE profile page.
The generic ingredient in IMATINIB MESYLATE is imatinib mesylate. There are thirty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the imatinib mesylate profile page.
The generic ingredient in IMATINIB MESYLATE is imatinib mesylate. There are thirty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the imatinib mesylate profile page.
Summary for 208302
| Tradename: | IMATINIB MESYLATE |
| Applicant: | Shilpa |
| Ingredient: | imatinib mesylate |
| Patents: | 0 |
Pharmacology for NDA: 208302
| Mechanism of Action | Protein Kinase Inhibitors |
Medical Subject Heading (MeSH) Categories for 208302
Suppliers and Packaging for NDA: 208302
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 208302 | ANDA | Ascend Laboratories, LLC | 67877-633 | 67877-633-90 | 90 TABLET, FILM COATED in 1 BOTTLE (67877-633-90) |
| IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 208302 | ANDA | Ascend Laboratories, LLC | 67877-634 | 67877-634-30 | 30 TABLET, FILM COATED in 1 BOTTLE (67877-634-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Jan 17, 2019 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE | ||||
| Approval Date: | Jan 17, 2019 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
